Robert W. Ashworth
Consigliere Generale presso ATYR PHARMA, INC.
Posizioni attive di Robert W. Ashworth
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ATYR PHARMA, INC. | Consigliere Generale | 06/10/2021 | - |
Storia della carriera di Robert W. Ashworth
Precedenti posizioni note di Robert W. Ashworth
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Consigliere Generale | 30/07/2018 | - |
| Corporate Officer/Principal | - | 01/09/2021 | |
| AYALA PHARMACEUTICALS, INC. | Responsabile della Conformità | 01/01/2015 | 01/01/2018 |
| Consigliere Generale | 01/01/2015 | 01/01/2018 | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Consigliere Generale | - | - |
| NPS PHARMACEUTICALS, INC. | Consigliere Generale | - | - |
Formazione di Robert W. Ashworth
| Massachusetts Institute of Technology | Doctorate Degree |
| St. John's University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| General Counsel | 5 |
| Compliance Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| ATYR PHARMA, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
- Borsa valori
- Insiders
- Robert W. Ashworth
- Esperienza
